Estee Lauder Companies Inc (EL) Stock Price Today
Aura AI Summary
Key Stats
- $30.10BMarket Cap
- -Volume
- Consumer StaplesSector
- $119.6152W High
- $67.2352W Low
- -Typical Hold Time
- $36.28BEnterprise Value
- 1.68%Div Yield
- -Trading Activity
Track Estee Lauder Companies Inc (EL) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Estee Lauder Companies Inc has traded between a low of $67.23 and a high of $119.61, highlighting its annual price range. Buy and sell Estee Lauder Companies Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Estee Lauder Companies Inc
Estee Lauder is the world leader in the global prestige beauty market, participating across skincare (56% of fiscal 2022 sales), makeup (26%), fragrance (14%), and haircare (4%) categories, with popular brands such as Estee Lauder, Clinique, MAC, La Mer, Jo Malone, Aveda, Bobbi Brown, Too Faced, Origins, Dr. Jart+, and The Ordinary. The firm operates in 150 countries, with 26% of fiscal 2022 revenue stemming from the Americas, 43% from Europe, the Middle East, and Africa, and 31% from Asia-Pacific. The company sells its products through department stores, travel retail, multi-brand specialty beauty stores, brand-dedicated freestanding stores, e-commerce, salons/spas, and perfumeries.
Most Recent News
Seagate surges on Q4 earnings beat and AI-driven data storage demand
Seagate Technology reported strong Q4 2026 results, beating earnings per share estimates with $5.71 and revenue of $3.63 billion, driven by high demand for data storage from the AI sector. The company showed solid financial health with a low debt-to-...

Replimune stock plunges 38% after FDA flags clinical trial issues for skin cancer drug
Replimune Group's stock fell sharply by 38.01% following FDA briefing documents that deemed its skin cancer drug trial data "not interpretable," signaling a major regulatory setback. Other companies like Travelzoo and Amkor Technology also saw signif...

Law firm probes if FBRX and SAFT shareholders got fair deals in recent buyouts
Halper Sadeh LLC is investigating whether shareholders of Forte Biosciences (FBRX) and Safety Insurance Group (SAFT) received fair treatment in their recent sales to argenx and Mapfre affiliates, respectively. The firm suspects insiders may have gain...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.